I am a
Home I AM A Search Login

Papers of the Week


2022 Mar 16


Pediatr Blood Cancer

Demand-only patient-controlled analgesia for treatment of acute vaso-occlusive pain in sickle cell disease.

Authors

Carullo V, Morrone K, Weiss M, Choi J, Gao Q, Pisharoty S, Moody K, Manwani D
Pediatr Blood Cancer. 2022 Mar 16:e29665.
PMID: 35294090.

Abstract

Sickle cell disease (SCD) is a chronic illness that is associated with frequent admissions for vaso-occlusive episodes (VOE). Opioids are frequently utilized in pain management, but dosing is often provider dependent. Opioids cause both short-term and long-term side effects, so the minimal effective dose is desired. This study examined demand-only patient-controlled analgesia (PCA) in pediatric patients.